RichardGGowerMD

PubMed

• 1 citations
  Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial.
  Sorena Kiani-Alikhan, Richard Gower, Timothy Craig, H James Wedner, Tamar Kinaciyan, Emel Aygören-Pürsün, Aleena Banerji, Jonathan A Bernstein, John Anderson, Phil Col...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2024 Mar 1
• 1 citations
  The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
  Marcus Maurer, Markus Magerl, Stephen Betschel, Werner Aberer, Ignacio J Ansotegui, Emel Aygören-Pürsün, Aleena Banerji, Noémi-Anna Bara, Isabelle Boccon-Gibod, Konrad...> ;Allergy. 2022 Jul 1
• 141 citations
  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.
  Marcus Maurer, Markus Magerl, Stephen Betschel, Werner Aberer, Ignacio J Ansotegui, Emel Aygören-Pürsün, Aleena Banerji, Noémi-Anna Bara, Isabelle Boccon-Gibod, Konrad...> ;The World Allergy Organization Journal. 2022 Mar 1
• Considerations for transition from subcutaneous to oral prophylaxis in the treatment of hereditary angioedema
  Richard G. Gower, Mary Wilber> ;Allergy, Asthma, and Clinical Immunology. 2021 Oct 9
• Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioed...
  William R Lumry, Bruce Zuraw, Marco Cicardi, Timothy Craig, John Anderson, Aleena Banerji, Jonathan A Bernstein, Teresa Caballero, Henriette Farkas, Richard G Gower, P...> ;Orphanet Journal of Rare Diseases. 2021 Jul 28
• 19 citations
  Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Pa...
  H. James Wedner, Emel Aygören-Pürsün, Jonathan A. Bernstein, Timothy J. Craig, Richard G. Gower, Joshua S. Jacobs, Douglas T. Johnston, William R. Lumry, Bruce L. Zura...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2021 Apr 15
• 76 citations
  Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asth...
  Tim W Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis, Borja G. Cosío, Njira L Lugogo, Arjun Mohan, Annie Burden, L. McDermott, Esth...> ;The Lancet. Respiratory Medicine. 2021 Mar 1
• 10 citations
  Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: fi...
  William R Lumry, Bruce Zuraw, Marco Cicardi, Timothy Craig, John Anderson, Aleena Banerji, Jonathan A Bernstein, Teresa Caballero, Henriette Farkas, Richard G Gower, P...> ;Orphanet Journal of Rare Diseases. 2021 Feb 15
• 19 citations
  Current medical management of hereditary angioedema: Follow-up survey of US physicians.
  Marc A. Riedl, Aleena Banerji, Richard G. Gower> ;Annals of Allergy, Asthma & Immunology. 2021 Mar 1
• 63 citations
  Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
  Bruce L. Zuraw, William R. Lumry, Douglas T. Johnston, Emel Aygören-Pürsün, Aleena Banerji, Jonathan A. Bernstein, Sandra C. Christiansen, Joshua S. Jacobs, Karl Sitz,...> ;The Journal of Allergy and Clinical Immunology. 2020 Oct 21
• 22 citations
  Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence
  Marcus Maurer, Werner Aberer, Rosana Câmara Agondi, Mona Al-Ahmad, Maryam Ali Al-Nesf, Ignacio J. Ansotegui, Rand Arnaout, Luisa Karla de Paula Arruda, Riccardo Asero,...> ;Allergy. 2020 Aug 1
• 9 citations
  Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings
  Timothy J. Craig, William R. Lumry, Marco Cicardi, Bruce L. Zuraw, Jonathan A. Bernstein, John Anderson, Joshua J. Jacobs, Marc A. Riedl, Michael E. Manning, Aleena Ba...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2019 Jul 1
• 17 citations
  Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency
  Timothy J. Craig, Paula J. Busse, Richard G. Gower, Douglas T. Johnston, Jay M. Kashkin, H. Li, William R. Lumry, Marc A. Riedl, D. Soteres> ;Annals of Allergy, Asthma & Immunology. 2018 Dec 1
• 56 citations
  Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
  William R. Lumry, Timothy J. Craig, Bruce L. Zuraw, Hilary Longhurst, James R. Baker, H. Henry Li, Jonathan A. Bernstein, John Anderson, Marc A. Riedl, Michael E. Mann...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2018 Sep 1
• 120 citations
  Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
  Hilary Longhurst, Marco Cicardi, Timothy J. Craig, Konrad Bork, Clive Grattan, James R. Baker, H. Li, Avner Reshef, James R. Bonner, Jonathan A. Bernstein, John Anders...> ;The New England Journal of Medicine. 2017 Mar 22
• 45 citations
  Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
  Marc A. Riedl, Anette Bygum, William R. Lumry, Markus Magerl, J.A. Bernstein, Paula J. Busse, Timothy J. Craig, Michael M. Frank, Jonathan M. Edelman, Debora Williams-...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2016 Sep 1
• 18 citations
  Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema.
  William R. Lumry, D. Soteres, Richard G. Gower, Kraig W. Jacobson, H. Henry Li, Hongzi Chen, Jennifer Schranz> ;Pediatric Allergy and Immunology. 2015 Nov 1
• 23 citations
  Current Medical Management of Hereditary Angioedema: Follow-up Survey of US Physicians
  Marc A. Riedl, Aleena Banerji, Richard G. Gower> ;The Journal of Allergy and Clinical Immunology. in Practice. 2015 Mar 1
• 39 citations
  Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema
  Jonathan A. Bernstein, Michael E. Manning, Henry Li, Martha V. White, James R. Baker, William R. Lumry, Mark Davis-Lorton, Kraig W. Jacobson, Richard G. Gower, Colin B...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2014 Jan 1
• 10 citations
  HAE update: determining optimal patient specific therapy.
  Richard G. Gower> ;Allergy and Asthma Proceedings. 2013 Jan 1
• 124 citations
  Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective
  Mario Sánchez-Borges, Riccardo Asero, Ignacio Ansotegui, Ilaria Baiardini, Jonathan A. Bernstein, G. Walter Canonica, Richard G. Gower, David A. Kahn, Allen P. Kaplan,...> ;The World Allergy Organization Journal. 2012 Nov 15
• 2 citations
  Hereditary angioedema: implications of treating a rare disease.
  Ira Kalfus, Richard G. Gower, Marc A. Riedl, Jonathan A. Bernstein, William R. Lumry, Michael M. Frank> ;Annals of Allergy, Asthma & Immunology. 2012 Aug 1
• 14 citations
  Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
  Richard G. Gower, William R. Lumry, Mark Davis-Lorton, Douglas T Johnston, Paula J. Busse> ;Allergy and Asthma Proceedings. 2012 May 1
• 35 citations
  Current medical management of hereditary angioedema: results from a large survey of US physicians.
  Marc A. Riedl, Richard G. Gower, Carole A. Chrvala> ;Annals of Allergy, Asthma & Immunology. 2011 Apr 1
• 42 citations
  Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
  Richard G. Gower, Paula J. Busse, Emel Aygören-Pürsün, Amin J. Barakat, Teresa Caballero, Mark Davis-Lorton, Henriette Farkas, D. Hurewitz, Joshua S. Jacobs, Douglas T...> ;The World Allergy Organization Journal. 2011 Feb 15
• Join now to see all

Journal Articles

• Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations  
  Gower, et al., Allergy and Asthma Proceedings, 5/1/2012
• Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1inhibitor deficiency: consensus report of an International Working Group  
  Cicardi et al., Allergy, 1/1/2012
• “Hereditary Angioedema: Implications of Treating a Rare Disease”. Letter to the Editor.  
  Kalfus et al., Annals of Allergy, 1/1/2012
• Hereditary Angioedema Caused by C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies  
  Gower, et al., World Allergy Organization Journal, 2/1/2011
• Clinical Presentation, Diagnosis, and Treatment of Hereditary Angioedema: An Overview  
  Gower, et al., Clinical Cornerstone. Focus on Angioedema, 1/1/2011
• Current Medical Management of Hereditary Angioedema: Results From a Large Survey of U.S. Physicians  
  Riedl et al., Annals of Allergy, Asthma & Immunology, 1/1/2011
• Improving Outcomes in Hereditary Angioedema: Clinical cases and Expert Opinion  
  ACAAI CME Newsletter, 1/1/2011
• Sublingual Immunotherapy: World Allergy Organization Position Paper 2009  
  Canonica GW, Bousquet J, Casale T, Lockey R, Baena-Cagnani C et al., World Allergy Organization Journal, 1/1/2009
• When is prophylaxis for hereditary angioedema necessary?  
  Craig et.al., Annals of Allergy, 1/1/2009
• Eradication of common pathogens at Days 2, 3, and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis  
  BMC Ear, Nose and Throat Journal, 1/1/2006
• Frozen Tears  
  John Strimas, M.D., Annals of Allergy, 5/1/2005
• Insurance Coverage for H1 Antihistamines: Implications for Quality Health Care and Public Safety  
  Position Statement of the AAAAI, ACAAI, and JCAAI, 11/18/2002
• Inhaled Mometasone Furoate Reduces Oral Prednisone Requirements While Improving Respiratory Function and Health-Related Quality of Life in Patients With Severe Persist...  
  Journal of Allergy and Clinical Immunology, 11/1/2000
• Asmanex Twisthaler: A New Inhaled Corticosteroid for the Treatment of Asthma  
  Key Pharmaceuticals, 8/25/1999
• Hypothalamic-Pituitary-Adrenal Axis Function During Treatment of Pediatric and Adolescent Asthma with Beclomethasone Dipropionate or Fluticasone Propionate  
  Advances in Therapy, 3/1/1997
• Join now to see all

Books/Book Chapters

• Clinical and Experimental Pheochromocytoma 
  Chapter: Cerebral Vasculitis Associated with Pheochromocytoma 
  Page 335 - 339Richard G. Gower, M.D.Editors: Dr. William M.Manger.Blackwell ScienceEdition seco,1996

Abstracts/Posters

• Management Plan for Patients with Hereditary Angioedema
  Gower RG, ACAAI Annual Meeting, 2011; WSAAI Annual Meeting, 2012; EAACI Annual Congress, 2012, Boston, MA, 2011; Kauai, HI, 2012; Geneva, Switzerland, 2012, 6/1/2012
• Management Plan for Patients with Hereditary Angioedema
  Gower, et al., ACAAI meeting, 2011; WSAAI meeting , 2012, Boston, MA, 2011; Kauai, HI, 2012, 1/1/2012
• A multi-site study evaluating patient perceptions of Olapatadine 0.2% in patients with allergic conjunctivitis
  WSAAI, 1/1/2008
• Once-daily ciclesonide is effective and well-tolerated in the treatment of Adult and Adolescent patients with mild-to-moderate Asthma
  AAAAI, 3/1/2005
• Reduction in Oral Corticosteriod Use with Mometasone Furoate Dry Powder Inhaler Improves Health-Related Quality of Life in Patients With Severe Persistent Asthma
  Jordana Schmier, Nancy Kline Leidy, and Richard G. Gower, Jnl. Of Asthma, European Respiratory Society, 2002; WSAAI Kona, 2003, Stockholm, Sweden, 2002; Kona, HI, 2003, 1/1/2003
• Cerebral Vasculitis Associated with Pheochromocytoma
  Richard G. Gower, M.D., Multiple locations, 1992, 1993, 1994, 1/23/1994
• Small Vessel Vasculitis Associated with Hepatitis B Surface Antigen
  Richard G. Gower, William F. Sausker, Peter F. Kohler, E. George Thorne, Rawle M. McIntosh, Journal of Allergy/Clinical Immunology, American Congress of Allergy, 1977, New York City, NY, 3/1/1977
• Leukocytoclastic Vasculitis - A Sequential Study of Immunoreactants and Cellular Reactants After Histamine Injection
  Richard G. Gower, W. Mitchell Sams, E. George Thorne, Peter F. Kohler, and Henry N. Claman, Journal of Investigative Dermatology, American Academy of Dermatology, 1976, Chicago, IL, 1/1/1977
• Ultraviolet-induced Changes in Residual Thermoluminescence from Gamma-irradiated Lithium Fluoride
  Richard G. Gower, William R. Hendee, and Geoffrey S. Ibbott, Health Physics, Multiple locations, 1969, 1/1/1969
• Join now to see all

Lectures

• HAE Update: Determining Optimal Patient Specific Therapy 
  West Palm Beach, FL - 6/1/2012
• The Evolving Science of Asthma 
  Great Falls, MT - 4/1/2012
• CVID: A Case Study 
  Kauai, HI - 1/1/2012
• HAE in Special Populations A Focus on Women 
  Boston, MA - 11/1/2011
• Hereditary Angioedema- New Trends in Managing a Complex Disease 
  Beijing, PRC - 9/1/2011
• Advances in hereditary Angioedema: From Prophylaxis to acute therapy 
  Coeur D’Alene, ID - 7/1/2011
• A clinician’s view on the role of nanofiltered C1 inhibitor (human) 
  Istanbul, Turkey - 6/1/2011
• Improving Outcomes in Hereditary Angioedema Clinical Cases and Expert Opinion: Individualization of Therapy 
  Phoenix, AZ - 11/1/2010
• US Experience with C1 esterase inhibitor 
  London, England - 6/1/2010
• State of the College 
  Multiple locations, 2008-2009 - 11/1/2009
• Improving the Quality of Life in patients with Severe Persistent Asthma 
  Multiple locations, 2009 - 11/1/2009
• How GARD is integrating the WHO Noncommunicable Diseases action plan and NCDnet: (Noncommunicable Disease Network) 
  1/1/2009
• Rhinitis Practice Parameter Update 
  Jerusalem, Israel - 12/5/2008
• Asthma 2008: The New NHLBI Guidelines 
  Spokane, WA - 2/1/2008
• Angioedema and Urticaria 
  Hong Kong and Xian, China - 12/9/2007
• Will Pay for Performance Improve Allergy and Asthma Care? 
  Dallas, TX - 11/13/2007
• Association of Allergic Rhinitis and Asthma: Chronic Allergic Respiratory Syndrome 
  Buenos Aires, Argentina - 6/6/2006
• Management of Respiratory Infections 
  Multiple locations, 2004-2005 - 12/20/2005
• Asthma/Allergy Link 
  Honolulu, HI, 1998; Anchorage, AK, 1998; Portland, OR, 2005 - 12/14/2005
• Anti-IgE Therapy: A Novel Treatment for Asthma 
  Multiple locations, 2001, 2003-2005 - 12/7/2005
• Mechanisms of Allergy and Asthma 
  Gleneden Beach, OR - 9/10/2005
• Allergic Rhinitis: Looking Beyond Quality of Life 
  Portland, OR, 2005; Milwaukee, WI, 2005 - 6/3/2005
• Management of Allergic Rhinitis 
  Coeur d'Alene, ID, 1998; Seattle, WA, 2001; Coeur d'Alene, ID, 2005 - 5/18/2005
• Allergies, Asthma, and Allergy Testing 
  San Francisco, CA - 4/14/2005
• The Role of Leukotriene Modifiers in the Treatment of Allergic Rhinitis and Asthma 
  Multiple locations, 2004-2005 - 3/29/2005
• Join now to see all

Other

• An Update of the Treatment of Allergic Rhinitis 
  National Teleconference
  5/8/2004
• Patient Preference in Allergic Rhinitis 
  National Teleconference
  10/24/2002
• Oral Inhaled Corticosteriod Therapy as the Cornerstone of Treatment in Persistent Asthma 
  Teleconference presentations to western regional physicians
  11/4/1997
• Significance and Treatment of Allergic Rhinitis 
  Teleconference for regional physicians
  9/25/1997
• Delivery Devices and Oral Inhaled Corticosteroids: Clinical Update in Asthma Management 
  Teleconference presentations to physicians and staff
  12/18/1996
• Join now to see all